Abstract
Background
Platelet-rich plasma(PRP) and prolotherapy(PRL) are regenerative treatment approaches in the knee osteoarthritis (KOA).
Aim
To see how efficient PRP and PRL are in treating KOA.
Methods
A total of 108 patients with a diagnosis of KOA who received either PRL, PRP, or exercise therapy and whose 3-month follow-up data were available were included in this retrospective study (PRL n = 35 or PRP n = 35, exercise n = 38). Visual Analogue Scale(VAS) and The Western Ontario McMaster University Osteoarthritis Index(WOMAC) were used as outcome measures at baseline, 1 month, and 3 months.
Results
There were no statistically significant differences between the three groups in terms of demographic parameters, baseline assessments of pain intensity, or WOMAC scores. At the first and third months, all groups showed a substantial improvement in the VAS activity, resting and WOMAC values as compared to before treatment(p < 0.05). When the groups were compared, the VAS activity, resting, and WOMAC values in PRP and PRL improved significantly in the first and third months compared to the exercise group. At one month, there was a statistically significant improvement in VAS activity and WOMAC pain and total scores compared to PRP and PRL, but this improvement was not significant at 3 months.
Conclusion
Pain and disability were significantly improved with PRL and PRP compared with exercise therapy. Although PRP is more effective than PRL in the first month after treatment, PRL may be preferred due to its low cost, long-term efficacy, and low complication rates due to the periarticular application.
Similar content being viewed by others
References
Smith T, Purdy R, Lister S, Salter C, Fleetcroft R, Conaghan P (2014) Living with osteoarthritis: a systematic review and meta-ethnography. Scand J Rheumatol 43(6):441–452
Stitik TPKJ-H, Stiskal D, Foye P, Nadler R, Wyss J et al (2011) Osteoarthritis. In: Frontera WR, editor. DeLisa Physical Medicine and Rehabilitation Phyladelphia: Lippincott Williams & Wilkins; p. 781–811
Rabago D, Van Leuven L, Benes L, Fortney L, Slattengren A, Grettie J et al (2016) Qualitative assessment of patients receiving prolotherapy for knee osteoarthritis in a multimethod study. The Journal of Alternative and Complementary Medicine 22(12):983–989
Fibel KH, Hillstrom HJ, Halpern BC (2015) State-of-the-art management of knee osteoarthritis. World Journal of Clinical Cases: WJCC 3(2):89
Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N (2007) Treatment of primary and secondary osteoarthritis of the knee. Evid Rep Technol Assess (Full Rep) 157:1–157
Otero M (2011) Inflammation in osteoarthritis. Curr Opin Rheumatol 23(5):471–478
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J et al (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64(4):465–474
Fernandes L, Hagen KB, Bijlsma JW, Andreassen O, Christensen P, Conaghan PG et al (2013) EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 72(7):1125–1135
Alderman D (2007) Prolotherapy for knee pain. Pract Pain Manage 7(6):70–79
Rabago D, Slattengren A, Zgierska A (2010) Prolotherapy in primary care practice. Primary Care: Clinics in Office Practice 37(1):65–80
Hauser RA, Maddela HS, Alderman D, Baehnisch G, Banner R, Blakemore PJ et al (2011) Journal of Prolotherapy International Medical Editorial Board consensus statement on the use of prolotherapy for musculoskeletal pain. Journal of Prolotherapy 3(4):744
Gamble R, Wyeth-Ayerst J, Johnson EL, Searle W-A, Beecham S (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43(9):1905–1915
Little CV, Parsons T, Logan S (2000) Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev (4)
Morelli V, Naquin C, Weaver V (2003) Alternative therapies for traditional disease states: osteoarthritis. Am Fam Physician 67(2):339–344
Council NR (2009) Initial national priorities for comparative effectiveness research. The National Academies Press, Washington, DC
Kon E, Filardo G, Drobnic M, Madry H, Jelic M, van Dijk N et al (2012) Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 20(3):436–449
Rahimzadeh P, Imani F, Seyed-Hamid-Reza Faiz M-R, Alebouyeh DA-E, Bahari L, Memarian A et al (2016) Adding intra-articular growth hormone to platelet rich plasma under ultrasound guidance in knee osteoarthritis: a comparative double-blind clinical trial. Anesth Pain Med 6(6)
Rahimzadeh P, Imani F, Faiz SHR, Entezary SR, Zamanabadi MN, Alebouyeh MR (2018) The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clin Interv Aging 13:73
Alderman D (2007) Prolotherapy for musculoskeletal pain. Pract Pain Manag 10–15
Yoshii Y, Zhao C, Schmelzer JD, Low PA, An K-N, Amadio PC (2014) Effects of multiple injections of hypertonic dextrose in the rabbit carpal tunnel: a potential model of carpal tunnel syndrome development. Hand 9(1):52–57
Linetsky F, Botwin K, Gorfine L, Jay GW, McComb B, Miguel R et al (2001) Regenerative injection therapy (RIT): effectiveness and appropriate usage. Position Paper Florida Acad Pain Med (FAPM) 1–12
Vora A, Borg-Stein J, Nguyen RT (2012) Regenerative injection therapy for osteoarthritis: fundamental concepts and evidence-based review. PM&R 4(5):S104–S109
Tucker J, Ericksen J, Goetz L, Elmore L (2014) Should clinical studies involving “regenerative injection therapy”, strive to incorporate a triad of outcome measures instead of only including clinical outcome measures? Osteoarthritis Cartilage 22(6):715–717
Dhillon RS, Schwarz EM, Maloney MD (2012) Platelet-rich plasma therapy-future or trend? Arthritis Res Ther 14(4):1–10
Tüzün E, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthritis Cartilage 13(1):28–33
Farpour HR, Fereydooni F (2017) Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: a randomized clinical trial. Electron Physician 9(11):5663
Laver L, Marom N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A (2017) PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage 8(4):341–364
Rezasoltani Z, Taheri M, Mofrad MK, Mohajerani SA (2017) Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis. J Pain Res 10:1179
Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderby R Jr (2008) Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthop Res 26(6):816–823
Sit RW, Chung VC, Reeves KD, Rabago D, Chan KK, Chan DC et al (2016) Hypertonic dextrose injections (prolotherapy) in the treatment of symptomatic knee osteoarthritis: a systematic review and meta-analysis. Sci Rep 6(1):1–12
Billesberger LM, Fisher KM, Qadri YJ, Boortz-Marx RL (2020) Procedural treatments for knee osteoarthritis: a review of current injectable therapies. Pain Res Manag 2020
Zhu Y, Yuan M, Meng H, Wang A, Guo Q, Wang Y et al (2013) Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage 21(11):1627–1637
Chang K-V, Hung C-Y, Aliwarga F, Wang T-G, Han D-S, Chen W-S (2014) Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil 95(3):562–575
Meheux CJ, McCulloch PC, Lintner DM, Varner KE, Harris JD (2016) Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthrosc J Arthrosc Relat Surg 32(3):495–505
Dumais R, Benoit C, Dumais A, Babin L, Bordage R, de Arcos C et al (2012) Effect of regenerative injection therapy on function and pain in patients with knee osteoarthritis: a randomized crossover study. Pain Med 13(8):990–999
Eslamian F, Amouzandeh B (2015) Therapeutic effects of prolotherapy with intra-articular dextrose injection in patients with moderate knee osteoarthritis: a single-arm study with 6 months follow up. Therapeutic advances in musculoskeletal disease 7(2):35–44
Hashemi M, Jalili P, Mennati S, Koosha A, Rohanifar R, Madadi F et al (2015) The effects of prolotherapy with hypertonic dextrose versus prolozone (intraarticular ozone) in patients with knee osteoarthritis. Anesth Pain Med 5(5)
Funding
This study was funded by the authors.
Author information
Authors and Affiliations
Contributions
All authors contributed to data analysis, drafting, and critical revision of the publication, and they agree to be responsible for all elements of it.
Corresponding author
Ethics declarations
Research involving human and animal participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Conflict of interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Medin Ceylan, C., Sahbaz, T. & Cigdem Karacay, B. Demonstrating the effectiveness of Platelet Rich Plasma and Prolotherapy treatments in knee osteoarthritis. Ir J Med Sci 192, 193–198 (2023). https://doi.org/10.1007/s11845-022-03168-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-022-03168-7